“showed a trend”

The European Organization for Research and Treatment of Cancer–Core Module diarrhea subscale score showed a trend toward improvement by an average of 16.7 ± 33.3 points ( P = 0.11).

Kaplan–Meier analyses showed a trend towards better 5-year survival rates (100% vs 60%; hazard ratio 0.23 [95% CI 0.03, 1.62], P = 0.11) among radiological responders vs non-responders at 24 month follow-up after aHSCT.

Elevated lysine showed a trend toward statistical significance ( P =0.11) in the homozygous mutant and was statistically significant in the compound heterozygote [WT, 272.80±61.47 vs Cps1 0/N674I , 366.30±67.68 ( P =0.009 vs WT)].

Out of 5 targets tested ( Klf4, Enos , Ctnnb1 , Bcl2l1 and Sma) , only the expression of Klf4 was significantly upregulated (p = 0.05), while the changes in Sma showed a trend (p = 0.11) without reaching a statistical significance (see Supplementary Fig.

Women had significantly better 11-item Alzheimer’s Disease Assessment Scale–Cognitive subscale (ADAS-Cog, 70-point scale) scores than men ( P = 0.001) and showed a trend toward younger age ( P = 0.11).

Compared with placebo, verapamil, which reduced mean pulse by 6 bpm and blood pressure by 5/4 mmHg, showed a trend to reduce mortality at 18 months (hazard ratio, 0.80; P = 0.11), and a significant reduction in the composite of cardiac death/MI (hazard ratio, 0.80; P = 0.03) 42 .

Baseline results showed a trend towards elevated SUVR CTX/CBL (+4.2% P =0.11) in the TG-GSM group compared with TG-VEH, mainly driven by the three individual animals mentioned above (labeled with arrows in Figure 3a ).

Robotic showed a trend toward lower mortality vs. open (OR 0.43, 95% CI 0.15–1.22, p = 0.11; Fig. 4 C).

The number of prior lines showed a trend toward an increased occurrence of t-MN (HR 1.11; 95% CI 0.98–1.25, p = 0.11), though this did not reach statistical significance at the 0.05 level.

Dose reduction showed a trend toward longer TTF (HR 0.66, 95% CI 0.40–1.10, p = 0.11), while age, sex, PS, and other AEs were not significantly associated with TTF.

However, in European Americans the paraspinous muscle index only showed a trend towards a similar protective relationship (p=0.11).

Paired pre- and post-chemotherapy NB samples showed a trend to increased frequency of CD57 high cells in post-chemotherapy residual tumors in 7 out of 8 informative tumor pairs ( Fig. 8B, C and Table 1 ; two-tailed p = 0.11 using the paired-sample Wilcoxon signed rank test).

MVA showed a trend towards worse PFS for NLR-change to <5 ( p = 0.11).

In addition, macrophage inflammatory protein-1α showed a trend for upregulation in loxoribine-treated cells prestimulated with interferon-β ( p = 0.11).

When the experiment was repeated with a 30-min delay, the main effect of action did not replicate (though showed a trend-level effect, F 1,29 = 2.74, P = 0.11), and the interaction of action and valence did replicate ( F 1,29 = 13.11, P = 0.001).

We also analyzed the time of SARS-CoV-2 clearance as a function of CD4 count and HIV status and found that while participants with a low CD4 count (<200) showed a trend of longer time to SARS-CoV-2 clearance (p=0.11), HIV viremia had no effect ( Figure 1—figure supplement 5 ).

The frequency of SNI showed a trend to be higher in patients with normal initial CRP values (141/297, 47.5%) than in patients with elevated initial CRP values (65/163, 39.9%) ( p = 0.11).

After SY treatment, HOMA‐IR showed a trend to decrease compared with the HFD group (4.16 ± 2.08 vs 6.45 ± 4.26, P = 0.11).

The concentration of valerate showed a trend (P = 0.11) to increase with the inclusion of MOS in the animals' diet.

The overall median score for sonographers showed a trend toward improvement from 79% (audit 1) to 81% (audit 2) to 85% (audit 3), ( p = 0.11).

Non-responders to the vaccine showed a trend toward increased naïve B cell percentage (β= 12.50, p=0.11) and decreased total memory B cell percentage (β=-12.54, p=0.080).

Complex III (2.5 μM Antimycin A) and pyruvate dehydrogenase‐supported mH 2 O 2 (10 mM pyruvate, 0.5 μM Rotenone to inhibit Complex I) were decreased in the Quad (−53%, P = 0.05) and WG (−60%, P < 0.05), while the diaphragm showed a trend for increased Complex III mH 2 O 2 (+35%, P = 0.11) and no differences in pyruvate dehydrogenase‐supported mH 2 O 2 between D2. mdx and WT (Supporting Information, Figure S4A and S4B ).

Serum levels of TNF-α showed a trend for higher expression in thick plaque psoriasis compared to thin plaque psoriasis ( p = 0.11), and its downstream cytokines, IL-6 and IL-8, were significantly higher in thick plaque psoriasis in comparison to thin plaque psoriasis ( p = 0.0035 for IL-6, p = 0.0036 for IL-8; Fig 5 ).

The BVS showed a trend toward a wider external elastic membrane area (12.86 ± 3.25 mm 2 ) when compared with EES/BES (11.58 ± 3.69 mm 2 ; p = 0.11).

The pooled results showed a trend toward a higher risk of neurovascular complications associated with TC-TAVR, without reaching statistical significance (RR, 1.36, 95% CI, 0.94–1.99, p = 0.11), and with no heterogeneity ( I 2 = 0%; Figure 3A ).